Technology solutions that shape the future

Technology solutions that shape the future

Identifying, supporting, patenting and marketing technical innovation by harvesting top technology talent to bring game-changing product to the market.

Nanotechnology and medicine

Nanotechnology and medicine

In the fight against cancer, nanotechnology introduces unique approaches to diagnosis and treatment that could not even be imagined with conventional technology.

Understanding Nanotechnology

Understanding Nanotechnology

Nanotechnology is the development and engineering of devices so small that they are measured on a molecular scale.

Early disease detection

Early disease detection

Dr. Edward Flynn has developed a nanotechnology-based, magnetic imaging method for early diagnosis of cancer.
Read the article

New ways to detect, treat cancer

New ways to detect, treat cancer

Edward Flynn could save lives with a new, ground-breaking technology intended to detect cancer much earlier than current techniques can.
Read the article

Our company

The Company's business model capitalizes on inventions and technology from which profits are created through licensing. MSI is dedicated to earning profit for its 8,600 shareholders by identifying, supporting, patenting and marketing technical innovation by harvesting top technology talent to bring game-changing product to the market.

We emphasize novel technology in the Nanomedicine space with the potential to be disruptive and the ability to establish sustainable businesses.

We are "patient capital" with experienced business building partners who bring the perspective of merchant bankers, not venture capitalists. Our approach to assist scientists to commercialize their work is by providing a forum within which the commercialization process is fostered through partnerships with existing companies (Fortune/1000 or larger). The entrepreneurial scientists and engineers who join us create personal success and wealth on an accelerated basis by virtue of ownership of publicly traded Manhattan Scientifics shares (OTC QB: MHTX).


Technology : Advenced Materials

Advanced Materials

Manhattan Scientifics has acquired the exclusive rights to the key patents and IP and will soon be positioned to enter into manufacturing and licensing agreements.

Technology : Nanomedecine


Manhattan Scientifics acquired Senior Scientific, LLC in 2011 and quickly began the cooperative work to commercialize its nanomedicine cancer detection technology. In 2017 Manhattan Scientifics spun out the cancer project as

Latest news & media

Manhattan Scientifics Celebrates Imagion Biosystems’ Milestones in Early Cancer Detection Technology

Manhattan Scientifics Inc., which provided the initial funding & currently owns more than 50 million shares of Imagion Biosystems Ltd. celebrates Imagion's remarkable progress in early cancer detection technology. Full story
May 31, 2023

Manhattan Scientifics Announces Early Results from Cancer Company

Manhattan Scientifics Inc., announces positive early results from Imagion Biosystems Cancer Diagnostic human study. Full story
March 17, 2022

Robert Proulx from Imagion Biosystems (IBX) | CEO Masterclass

Peter Switzer is joined by the CEO of medical imaging company Imagion Biosystems (IBX), Robert Proulx. Full video
March 2020

Bob Proulx at NobleCon12

This video captures Senior Scientific COO Bob Proulx's address to investors at the January 2016 NobleCon meeting, where he presents the unique properties of magnetic relaxometry and explains how it can be used to catch cancer in its earliest stages, when life-saving treatments are most effective. NobleCon is an annual conference attended by investors who want to learn about the most promising new technologies and opportunities. Full video
January 2016